Dietary antioxidant intake, wheeze and atopic status in 5-year-old children

2008 ◽  
Vol 21 (3) ◽  
pp. 286-287
Author(s):  
S. Patel ◽  
C. Murray ◽  
G. Kerry ◽  
A. Woodcock ◽  
A. Custovic
2018 ◽  
Vol 17 (4) ◽  
pp. 305-313 ◽  
Author(s):  
Jia-Rong Wu ◽  
Eun Kyeung Song ◽  
Debra K Moser ◽  
Terry A Lennie

Background: Heart failure is a chronic, burdensome condition with higher re-hospitalization rates in African Americans than Whites. Higher dietary antioxidant intake is associated with lower oxidative stress and improved endothelial function. Lower dietary antioxidant intake in African Americans may play a role in the re-hospitalization disparity between African American and White patients with heart failure. Objective: The objective of this study was to examine the associations among race, dietary antioxidant intake, and cardiac event-free survival in patients with heart failure. Methods: In a secondary analysis of 247 patients with heart failure who completed a four-day food diary, intake of alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein, zeaxanthin, lycopene, vitamins C and E, zinc, and selenium were assessed. Antioxidant deficiency was defined as intake below the estimated average requirement for antioxidants with an established estimated average requirement, or lower than the sample median for antioxidants without an established estimated average requirement. Patients were followed for a median of one year to determine time to first cardiac event (hospitalization or death). Survival analysis was used for data analysis. Results: African American patients had more dietary antioxidant deficiencies and a shorter cardiac event-free survival compared with Whites ( p = .007 and p = .028, respectively). In Cox regression, race and antioxidant deficiency were associated with cardiac event-free survival before and after adjusting for covariates. Conclusion: African Americans with heart failure had more dietary antioxidant deficiencies and shorter cardiac event-free survival than Whites. This suggests that encouraging African American patients with heart failure to consume an antioxidant-rich diet may be beneficial in lengthening cardiac event-free survival.


2018 ◽  
Vol 52 (2) ◽  
pp. 1800507 ◽  
Author(s):  
Annabelle Bédard ◽  
Kate Northstone ◽  
John W. Holloway ◽  
A. John Henderson ◽  
Seif O. Shaheen

2020 ◽  
Vol 20 (2) ◽  
pp. 984-990
Author(s):  
Atena Mahdavi ◽  
Amirmansour Alavi Naeini ◽  
Mohammadreza Najafi ◽  
Mohammadreza Maracy ◽  
Mohammadreza Aghaye Ghazvini

Background: There is a limited amount of data regarding levetiracetam (LEV), an antiepileptic drug. Objective: This study was conducted to assess the effect of LEV on antioxidant status and liver enzymes. Method: In this case-control study, 33 epileptic patients under treatment with LEV for at least 6 months were compared with 35 healthy subjects. We measured serum total antioxidant capacity (TAC), salivary superoxide dismutase (SOD), alanine aminoteransferase (ALT), and aspartate aminoteransferase (AST) levels in both groups. Dietary intakes were collected using a Food Frequency Questionnaire (FFQ). Result: The level of TAC in the healthy subjects was significantly higher than it was in the patients (P=0.02), but the mean of ALT (P=0.02) and AST (P=0.03) was significantly higher in the patients in comparison with the controls. Mean salivary SOD showed no difference between the two groups. In the patients, the duration of drug use was inversely correlated with serum TAC (p=0.04) and had a direct correlation with ALT (p=0.01) and AST (p=0.03.). Conclusion: The results of our study indicated that LEV increased liver enzymes Also, treatment with this drug did not improve oxidative stress, but this could be due to the different in the dietary antioxidant intake. Routine screening of the liver and antioxidant enzymes in patients with chronic use of LEV is recommended. Keywords: Levetiracetam; antioxidant; liver enzymes; epilepsy.


2015 ◽  
Vol 77 (1) ◽  
pp. 68-82 ◽  
Author(s):  
May A. Beydoun ◽  
Marie T. Fanelli-Kuczmarski ◽  
Melissa H. Kitner-Triolo ◽  
Hind A. Beydoun ◽  
Jay S. Kaufman ◽  
...  

2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 190-190
Author(s):  
Seok Shin Tan

Abstract Objectives This study aimed to investigate the association between dietary antioxidant intake and blood lactate level among 20–55 years old Malaysian adults. Methods Subjects (N = 80) of this cross-sectional study were recruited through convenience sampling. Sole Fitness LCB Upright Bike was used to conduct the modified Wingate Anaerobic Test. Dietary antioxidant level was assessed by using Malaysian Adult Nutrition Survey (MANS) 2014 food frequency questionnaire. Short Form International Physical Activity Questionnaire (IPAQ) was used to assess the physical activity level of the subjects. Blood lactate concentration was assessed by The Edge TM blood lactate analyzer, before and after exercise. Saliva samples were collected from subjects for total antioxidant capacity determination using the 2,2-diphenyl-1- picryl-hydrazyl test of saliva (DPPHS) assay. Data was analyzed using SPSS version 25.0. Results The median of total antioxidant intake among Malaysian male and female adults were 1030.64 (734.74) and 9392.90 (10360.44) mg/day, respectively. A significant difference between the means blood lactate level before and after exercise was observed, however, no significant difference in the mean salivary total antioxidant capacity (TAC) before and after exercise. No significant association observed between the total antioxidant intake and salivary TAC before exercise for both males and females, whereas a significant positive moderate association was observed after exercise for females. A significant inverse moderate association between blood lactate level and salivary TAC before exercise was observed among the males in the present study but no association found after exercise for both males and females. Conclusions Present study indicated no significant association between the total dietary antioxidant intake and blood lactate level among Malaysian adults aged 20–55 years old. Future research with larger sample size should develop strategically to confirm these initial findings. Funding Sources International Medical University, Malaysia


Diabetes Care ◽  
2004 ◽  
Vol 27 (2) ◽  
pp. 362-366 ◽  
Author(s):  
J. Montonen ◽  
P. Knekt ◽  
R. Jarvinen ◽  
A. Reunanen

Sign in / Sign up

Export Citation Format

Share Document